{"query":"nicox.com","mode":"domain","best":{"domain":"nicox.com","status":"valid","tier":"listed","authority":47,"verified":false,"title":"Nicox: Visible Science","summary":"Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs.","country":"FR","country_source":"ip","llms_txt":"https://nicox.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-21T09:37:54.786Z","agent_terms":null,"categories":["marketing","healthcare"],"capabilities":[],"inferred_tags":["drug development","ophthalmology","pharmaceutical pipeline","investor relations","ncx 470"],"audience":"mixed","agent_uses":["read_docs"],"language":"fr","platform_generated":true,"agent_summary":"Nicox, a pharmaceutical company, offers pipeline and regulatory updates (e.g. NCX 470 NDA) plus investor governance and financial information in French and Engl","llms_txt_cached":"https://agentwebmap.com/v1/domain/nicox.com/llms.txt","agentic":"documentation","section_keys":["category","documents","leadership-team","optional","pages","popup-themes","popups","products","videos","webcasts"],"section_partial":false,"section_indexed_at":"2026-10-21T14:17:00.360Z","why":["authority 47 (listed)","checked 2050 minutes ago"]},"read":{"llms_txt":"https://nicox.com/llms.txt","llms_full_txt":null,"nested_llms_txt":[]},"terms":null,"health":{"ok":true,"status":"valid","tier":"listed","authority":47,"last_checked":"2026-10-21T09:37:54.786Z","checked_minutes_ago":2050,"stale":true,"max_age_seconds":86400,"live_checked":false,"http_status":200,"last_valid":"2026-10-21T09:37:54.786Z","content_hash":"95caa882164817eaa5e319a3613140ad"},"sources":[],"match":{"strength":"domain","reason":"Exact domain or its registered publisher."},"provenance":{"selection":"directory","verification":"domain_ownership","terms":"unknown","excerpts":"publisher_link_metadata","health":"stored_crawl"},"alternatives":[]}